Max Financial Q2 FY27 Earnings Call — Analysis (NSE: MFSL)
Max Financial reported strong H1 FY27 VNB growth of 21% to ₹1,180 Cr with VNB margins expanding 210 bps to 25.4%, while navigating draft regulatory EoM caps.
Result quality: stable — Steady quarter. Management sentiment: optimistic.
The take
H1FY27 Revenue (ex-investment income) ₹17,484 Cr ( +16% YoY ) . Guidance raised — FY27 full-year fy27 vnb margin closer to 26% . But missed — Margin expansion through protection & annuity m… . New story: Margin expansion through protection & annuity m… .
Results
H1 FY27 consolidated PAT surged 137% YoY to ₹219 Cr, VNB grew 21% to ₹1,180 Cr with Q2 VNB margin at 27.0%, and EV reached ₹31,437 Cr (+17% YoY).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Consolidated PAT | ₹219 Cr | +137% | yoy · H1FY27 · vs H1FY26 |
| Revenue (ex-investment income) | ₹17,484 Cr | +16% | yoy · H1FY27 · vs H1FY26 |
| Gross Written Premium | ₹18,066 Cr | +17% | yoy · H1FY27 · vs H1FY26 |
| Value of New Business (VNB) | ₹1,180 Cr | +21% | yoy · H1FY27 · vs H1FY26 |
| VNB Margin | 25.4% | +210bps | yoy · H1FY27 · vs H1FY26 (23.3%) |
| VNB Margin (Q2) | 27.0% | none · Q2FY27 · Q2FY27 standalone | |
| Embedded Value | ₹31,437 Cr | +17% | point_in_time · H1FY27 · Sep-2026 |
| Operating RoEV | 17.3% | +100bps | yoy · H1FY27 · vs H1FY26 |
| AUM | ₹206,000 Cr | +11% | point_in_time · H1FY27 · Sep-2026 |
| Solvency Ratio | 197% | point_in_time · H1FY27 · Sep-2026 |
Guidance
Management raised confidence towards ending FY27 near the upper end of its 25–26% VNB margin guidance and expects H2 APE growth to accelerate over H1.
What management committed to
- Axis Max Life will deliver a full‑year FY27 VNB margin that is closer to 26% than to the previously guided 25-26% range, indicating an upgrade in margin trajectory. — closer to 26%, FY27
- Axis Max Life will achieve the proposed reduced Expenses of Management to GWP ratio of 12.5% within the regulatory transition period (approx. 2.5-5 years) by optimizing commission mix and driving operational cost efficiencies. — 12.5% EoM ratio, FY30
- Axis Max Life expects its counter share in the Axis Bank channel to increase under the new regulatory framework and through the ongoing Parivartan Plus program. — counter share to only go up, FY28
- Axis Max Life's persistency will no longer deteriorate and will start improving from Q3FY27 onwards as the base of the discontinued non-participating product cohort diminishes. — no longer deteriorate, in fact improve, FY27 H2
- Axis Max Life does not require an immediate equity capital raise, remaining comfortably above its internal solvency thresholds without seeking new capital. — no immediate lookout for capital, FY28
Key themes
VNB expansion, product diversification, and EoM adaptability
How the narrative shifted
- Margin expansion through protection & annuity mix: Management upgraded the VNB margin guidance from the '25-26%' aspirational range to 'closer to 26%', explicitly stating mix is the dominant factor.
- Multi‑channel distribution resilience: The Axis Bank narrative shifts to focus heavily on emerging channel contribution (now 30% of Axis sales) and the Parivartan Plus transformation program.
- Axis Bank partnership and capital optimisation: Management directly connects the partnership to the new regulatory paradigm, predicting distributor consolidation in favor of top players.
- Navigating yield curve volatility: The narrative pivots the driver of margins entirely to structural product mix, downplaying the transitory macro benefit that was heavily featured in the prior call.
- Regulatory tailwinds (RBC & structure simplification): The dominant macro story resets from passive tailwinds to proactive headwind navigation, reframed as a strategic catalyst that reinforces the company's diversified moat.
- Digital and AI transformation driving operational efficiency: Newly detailed as a distinct, results-driven thread linking technology directly to cost efficiency and competitive differentiation, rather than a passing capability.
- EoM regulation as competitive moat: bullish
Operational commentary
- Product mix diversification: Retail APE mix in Q2 stood balanced across ULIP (37%), Annuity (19%), Par (15%), Non-Par (15%), and Protection & Health (14%).
- Annuity and Retirement traction: Annuity business surged 130% YoY in Q2 FY27 driven by the launch of 'Smart RISE' (variable annuity), contributing ~8% of total APE.
- Axis Bank and proprietary channel performance: Axis Bank channel grew 4% YoY in Q2 FY27 (affected by delayed protection launch and ULIP softness), while other retail partners grew 19% and E-commerce grew 29%.
- Regulatory consultation readiness: Evaluated proposed IRDAI Expenses of Management (EoM) caps; management estimates ~5–7% relief from commission and GST realignment and 2–3% from internal efficiency, confirming ~95% of business is resilient to distributor consolidation.
- Persistency metrics: 13th month persistency moderated to 83% (vs 85% prior year) due to discontinued non-par designs, while long-term persistency cohorts (37th, 49th, and 61st month) achieved all-time highs.
Analyst Q&A
Q. How will Axis Max Life achieve the proposed 15% and eventual 12.5% EoM cap under the draft IRDAI consultation paper?
Commission realignment towards renewal plus GST adjustment accounts for a 5-7% gain, and internal cost/operational efficiencies will deliver another 2-3%, bringing the 22.5% ex-GST EoM smoothly towards the targets over 2.5 years.
Q. Why did Axis Bank channel growth moderate to 4% in Q2 FY27 and is counter share dropping?
Moderation was due to softer market demand for ULIPs and a delayed rollout of Smart Term Plan Plus (STPP); counter share dipped slightly to 62-63% in Aug-Sep but is recovering back towards normal 65% levels under Project Parivartan Plus.
Q. What drove the 13th-month persistency decline from 85% to 83%?
Stress was concentrated in certain Non-Par savings products launched in the prior year, which were fully discontinued in March 2026; persistency is expected to stabilize and improve in Q3/Q4 FY27.
Q. What is the planned transition approach for the in-force book under Ind AS / IFRS 17?
Management stated that it is premature to comment on the specific accounting transition approach for in-force book at this stage, though FY27 comparatives will be provided on the April 1, 2026 transition date.
Research and educational content only. Not investment advice.